Latest Breaking News On - Retinal vascular occlusion - Page 1 : comparemela.com

Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® $25.6 million for EMPAVELI® Anticipates CHMP opinion for pegcetacoplan.

United statesPhilip ferroneMeredith kayaLissa pavlukCedric francoisExchange commission onApellis pharmaceuticals incAdvisory committee on immunization practicesEuropean unionExchange commissionEuropean medicines agencyNocturnal hemoglobinuriaSenior convertible notesSafety informationRetinal detachmentsRetinal vascular occlusion

Apellis Appoints Leading Expert Dr Philip Ferrone as Chief Medical Retina Advisor

WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that leading retina specialist P.

Union collegeNew yorkUnited statesMeredith kayaPhilip ferroneLissa pavlukCaroline baumalAmerican society of retina specialistsApellis pharmaceuticals incDuke university eye centerExchange commission onExchange commissionHarvard medical schoolChief medical retina advisorAmerican societyRetina specialists

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Generated $397 million in full year 2023 revenues, including $275 million for SYFOVRE® and $91 million for EMPAVELI® Strong SYFOVRE launch, with more than 160,000 total doses distributed in 2023.

United statesLissa pavlukCedric francoisMeredith kayaAmerican academy of ophthalmologyExchange commissionApellis pharmaceuticals incAmerican society of nephrologyEuropean unionExchange commission onCommittee for medicinal products human useEuropean medicines agencyAdvisory committee on immunization practicesAmerican society of hematologyRecent business highlightsAmerican academy

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLissa pavlukMeredith kayaCedric francoisExchange commissionAdvisory committee on immunization practicesEuropean unionExchange commission onApellis pharmaceuticals incAnnounces preliminary fourth quarterFull yearOctober injectorHealthcare conference presentationHealthcare conferenceSafety informationRetinal detachments

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMeredith kayaLissa pavlukCedric francoisAdvisory committee on immunization practicesExchange commissionExchange commission onApellis pharmaceuticals incEuropean unionOctober injectorHealthcare conference presentationHealthcare conferenceSafety informationRetinal detachmentsRetinal vascular occlusionVascular endothelial growth factor